INNOVUS PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - November 16, 2015

Attached files

file filename
10-Q - FORM 10-Q - INNOVUS PHARMACEUTICALS, INC.innv10q_sep302015.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - INNOVUS PHARMACEUTICALS, INC.ex31-1.htm
EXHIBIT 32.1
 
CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report on Form 10-Q of Innovus Pharmaceuticals, Inc. (the “Corporation”) for the quarter ended March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Bassam Damaj, principal executive officer of the Corporation, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
 
 
(1)
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
 
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation as of September 30, 2015.
 
Dated: November 16, 2015
  
/s/ Bassam Damaj
   
Bassam Damaj, President and Chief Executive Officer
(Chief Executive and Financial Officer)

 


INNOVUS PHARMACEUTICALS, INC. Reports